Stichting Alrijne Zorggroep

Neuromuscular Disorders

Research activity includes piriformis hypertonia, with clinical attention to piriformis syndrome and related muscle overactivity affecting movement and function.

  • Muscle hypertonia
  • Piriformis syndrome
  • Neuromuscular pain

The sponsor’s clinical interest in this area is centered on functional improvement and symptom relief in patients with localized muscular dysfunction.

Sports Medicine

Clinical research also addresses sports resumption after treatment for muscle-related pain and mobility limitation, reflecting interest in return-to-activity outcomes.

  • Return to sport
  • Activity recovery
  • Functional performance

This area focuses on restoration of physical participation after intervention for movement-limiting symptoms.

Botulinum Toxin Therapy

The sponsor is involved in research on BoNT-A injection for muscle overactivity and pain associated with piriformis syndrome.

  • Botulinum toxin type A
  • Injection therapy
  • Muscle relaxation

Interest in this therapeutic domain includes the use of targeted treatment for localized muscular disorders.

Rehabilitation and Functional Recovery

Clinical work extends to recovery of daily and athletic function after treatment for pain and mobility restriction linked to piriformis hypertonia.

  • Mobility restoration
  • Functional recovery
  • Post-treatment rehabilitation

Research interest in this domain is tied to improving physical capability after intervention in a hospital-based care setting.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effect of Botulinum Toxin Type A and Physiological NaCl 0.9% in Patients with Piriformis Syndrome

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands